1
项与 KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences) 相关的临床试验 / Active, not recruiting临床1期IIT Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation
This phase I trial studies the best dose and side effects of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA (iExosomes) in treating participants with pancreatic cancer with KrasG12D mutation that has spread to other places in the body. iExosomes may work better at treating pancreatic cancer.
100 项与 KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences) 相关的临床结果
100 项与 KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences) 相关的转化医学
100 项与 KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences) 相关的专利(医药)
100 项与 KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences) 相关的药物交易